Tiny device could fix leaky heart valves without cutting chest open
NCT ID NCT07671820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early trial tests a new device called Anchord that repairs leaky mitral valves without open-heart surgery. It will include 5 people with severe valve leakage who are too high-risk for standard surgery. The goal is to see if the device is safe and can reduce the leak, improving symptoms like shortness of breath.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Anchord Mitral Chordal Repair device
- What this could lead to
- If it works, this could offer a less invasive option for people with leaky heart valves who are too high-risk for open-heart surgery.
- What could go wrong
- This is a very early first-in-human trial with only 5 participants, so results may not apply broadly. The device could fail to reduce the leak or cause complications like infection or device movement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Can a new valve device fix a leaky heart without open surgery?
- Can mixed reality make heart valve surgery safer and faster?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- New heart valve device could spare High-Risk patients from Open-Heart surgery
- First-in-Human trial aims to offer new hope for patients with leaky heart valves who Can't have surgery